Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP211421.RAD75srY4AMzkftU5B6sQZgEv083rSdx9c4UDuslazuDY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP211421.RAD75srY4AMzkftU5B6sQZgEv083rSdx9c4UDuslazuDY130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP211421.RAD75srY4AMzkftU5B6sQZgEv083rSdx9c4UDuslazuDY130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP211421.RAD75srY4AMzkftU5B6sQZgEv083rSdx9c4UDuslazuDY130_provenance.
- NP211421.RAD75srY4AMzkftU5B6sQZgEv083rSdx9c4UDuslazuDY130_assertion description "[The results demonstrate that patients with cGVHD had a higher incidence of HP 2-2 phenotype (43.8%), in comparison to the patients without cGVHD (0%) and normal donors (18.7%), suggesting the possibility that specific Hp polymorphism may play a role in the development of cGVHD after allo-HCT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211421.RAD75srY4AMzkftU5B6sQZgEv083rSdx9c4UDuslazuDY130_provenance.
- NP211421.RAD75srY4AMzkftU5B6sQZgEv083rSdx9c4UDuslazuDY130_assertion evidence source_evidence_literature NP211421.RAD75srY4AMzkftU5B6sQZgEv083rSdx9c4UDuslazuDY130_provenance.
- NP211421.RAD75srY4AMzkftU5B6sQZgEv083rSdx9c4UDuslazuDY130_assertion SIO_000772 19379511 NP211421.RAD75srY4AMzkftU5B6sQZgEv083rSdx9c4UDuslazuDY130_provenance.
- NP211421.RAD75srY4AMzkftU5B6sQZgEv083rSdx9c4UDuslazuDY130_assertion wasDerivedFrom befree-20140225 NP211421.RAD75srY4AMzkftU5B6sQZgEv083rSdx9c4UDuslazuDY130_provenance.
- NP211421.RAD75srY4AMzkftU5B6sQZgEv083rSdx9c4UDuslazuDY130_assertion wasGeneratedBy ECO_0000203 NP211421.RAD75srY4AMzkftU5B6sQZgEv083rSdx9c4UDuslazuDY130_provenance.
- befree-20140225 importedOn "2014-02-25" NP211421.RAD75srY4AMzkftU5B6sQZgEv083rSdx9c4UDuslazuDY130_provenance.